TY - JOUR AU - Kenter, Robin Maria Francisca AU - Schønning, Adrian AU - Inal, Yavuz PY - 2022 DA - 2022/10/21 TI -互联网提供的成人ADHD (MyADHD)自助:可用性研究JO - JMIR Form Res SP - e37137 VL - 6 IS - 10 KW -可用性测试KW -用户评价KW -自我引导干预KW -互联网传递KW -自助KW -患有注意缺陷/多动障碍的成年人KW -干预KW -可用性研究KW -护理需求KW -可用性AB -虽然存在有效的药物治疗，但许多患有注意力缺陷/多动障碍(ADHD)的成年人更喜欢使用非药物治疗来控制他们的症状。互联网提供的自助干预有可能以相对较低的成本解决成人ADHD患者报告的未满足的支持性护理需求。然而，如果干预不能提供最佳的功能、内容和布局，它可能会降低依从性和参与度，并可能损害此类干预的有效性。因此，有必要对互联网自助干预的可用性和影响其可用性的因素进行研究。目的:本研究评估网络自助干预成人多动症(MyADHD)的可用性。主要目标是:(1)收集关于可用性的定性和定量数据;(2)确定可用性问题。方法:采用个体有声思考访谈和分阶段可用性测试(N=5)，从功能、内容和设计三个方面评估MyADHD干预措施的可用性。MyADHD最终用户提供迭代反馈，以最大限度地提高参与度和可用性。 They performed tasks involved in operating the intervention and provided “think-aloud” commentary and postsession usability ratings. The interviews were recorded, transcribed verbatim, and analyzed. Results: Participants were satisfied with the overall usability of the program. The average perceived usability score out of 100 was 70 for the first round of testing and improved to 77.5 after applying modifications, with a mean score of 75.5 (SD 5.9) for all rounds of usability testing. The analysis of the interviews revealed 3 central themes: functionality, content, and layout. Conclusions: Optimizing the usability of internet-delivered self-guided interventions is a critical step in the design and development process. The usability testing in this study provided valuable information from users’ perspectives on the content and platform of the intervention. Analysis revealed the need for intervention enhancement with regard to design, functionality, and content from the perspective of potential end users. Overall, participants saw value in the MyADHD intervention and were confident that they could use it for the self-management of symptoms and expressed the desire to use the entire intervention when it becomes available. Through this development process, we produced an intervention that is likely to be used successfully and is ready for deployment in a randomized controlled trial. Trial Registration: ClinicalTrials.gov NCT04511169; https://clinicaltrials.gov/ct2/show/NCT04511169 SN - 2561-326X UR - https://formative.www.mybigtv.com/2022/10/e37137 UR - https://doi.org/10.2196/37137 UR - http://www.ncbi.nlm.nih.gov/pubmed/36269662 DO - 10.2196/37137 ID - info:doi/10.2196/37137 ER -